Tizanidine
- Product NDC
- 71610-451
- 11-digit product format
- 716100451
- Labeler code
- 71610
- Product ID
- 71610-451_dd861284-8693-4273-bd3e-451c5c333fc2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2003-12-11
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-451 | TIZANIDINE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20200806_95b72e1b-e8b8-407e-845a-8a52ed962806.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-451-16 | 71610045116 | 6000 TABLET in 1 BOTTLE (71610-451-16) | 6000 tablet | 2020-07-30 | 0000-00-00 | No | No | Current |